Oral anticancer medicines are well established in healthcare, shifting greater responsibility on the patient to self-manage their treatment. Yet, a recent literature review showed adherence rates to oral anticancer treatments are as low as 40%. While there is a range of supportive services for individuals living with cancer, there is relatively little support that addresses treatment nonadherence. The latest white paper from the in-house health psychology experts at Atlantis Healthcare explores insights around oral oncology treatment, and examines best practices for successful pharma interventions in patient support.